These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22348365)

  • 81. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
    Hamilton CA
    J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.
    Game F
    Nephron Clin Pract; 2014; 126(1):14-8. PubMed ID: 24434725
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
    Libardi F; Sirolli V; Cappelli P; Bonomini M
    G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Newer anti - diabetic therapies and chronic kidney disease].
    Di Lullo L; Ronco C; Barbera V; Cozzolino M; Santoboni F; Villani A; De Pascalis A; Bellasi A
    G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177092
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Achieving glycemic control in patients with type 2 diabetes and renal impairment.
    Avogaro A; Schernthaner G
    Acta Diabetol; 2013 Jun; 50(3):283-91. PubMed ID: 23212669
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Management of diabetes in patients with chronic kidney disease.
    Ahmed Z; Simon B; Choudhury D
    Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].
    Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
    Nefrologia; 2014; 34(1):34-45. PubMed ID: 24611186
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Incretin-based therapy in chronic kidney disease.
    Pinelli NR; Moore CL; Tomasello S
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):439-49. PubMed ID: 20727514
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Management of drugs affecting blood glucose in diabetic patients with renal failure.
    Charpentier G; Riveline JP; Varroud-Vial M
    Diabetes Metab; 2000 Jul; 26 Suppl 4():73-85. PubMed ID: 10922977
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP; Stam D
    Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.